AirSculpt Technologies, Inc. Deferred Federal Income Tax Expense (Benefit)
AirSculpt Technologies, Inc. (AIRS) reported Deferred Federal Income Tax Expense (Benefit) of -$4.78 million for the 12-month period ending 2025-12-31, per its 10-K/A filed 2026-04-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-04-06
- AirSculpt Technologies, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was -$4.78M.
- AirSculpt Technologies, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$95.00K, a 107.97% decline from fiscal 2023.
- AirSculpt Technologies, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was $1.19M, a 7.48% increase from fiscal 2022.
- AirSculpt Technologies, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was $1.11M, a 356.38% increase from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$4.78M 10-K/A · filed 2026-04-06 |
| 2024-12-31 | -$95.00K 10-K/A · filed 2026-04-06 |
| 2023-12-31 | $1.19M 10-K/A · filed 2026-04-06 |
| 2022-12-31 | $1.11M 10-K · filed 2025-03-14 |
| 2021-12-31 | $243.00K 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |